These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32050722)

  • 1. Nucleoside Diphosphate Kinase B Contributes to Arrhythmogenesis in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Arrhythmogenic Right Ventricular Cardiomyopathy.
    Buljubasic F; El-Battrawy I; Lan H; Lomada SK; Chatterjee A; Zhao Z; Li X; Zhong R; Xu Q; Huang M; Liao Z; Lang S; Cyganek L; Zhou X; Wieland T; Borggrefe M; Akin I
    J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32050722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
    Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
    Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy.
    El-Battrawy I; Zhao Z; Lan H; Cyganek L; Tombers C; Li X; Buljubasic F; Lang S; Tiburcy M; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou XB; Akin I
    Europace; 2018 Jun; 20(FI1):f46-f56. PubMed ID: 29566126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SK4 K
    Haron-Khun S; Weisbrod D; Bueno H; Yadin D; Behar J; Peretz A; Binah O; Hochhauser E; Eldar M; Yaniv Y; Arad M; Attali B
    EMBO Mol Med; 2017 Apr; 9(4):415-429. PubMed ID: 28219898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleoside diphosphate kinase B-activated intermediate conductance potassium channels are critical for neointima formation in mouse carotid arteries.
    Zhou XB; Feng YX; Sun Q; Lukowski R; Qiu Y; Spiger K; Li Z; Ruth P; Korth M; Skolnik EY; Borggrefe M; Dobrev D; Wieland T
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1852-61. PubMed ID: 26088577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling incomplete penetrance in arrhythmogenic cardiomyopathy by human induced pluripotent stem cell derived cardiomyocytes.
    De Bortoli M; Meraviglia V; Mackova K; Frommelt LS; König E; Rainer J; Volani C; Benzoni P; Schlittler M; Cattelan G; Motta BM; Volpato C; Rauhe W; Barbuti A; Zacchigna S; Pramstaller PP; Rossini A
    Comput Struct Biotechnol J; 2023; 21():1759-1773. PubMed ID: 36915380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Electrical, Biomolecular, and Immunologic Phenotypes in a Novel Patient-Derived Stem Cell Model of Desmoglein-2 Mutant ARVC.
    Hawthorne RN; Blazeski A; Lowenthal J; Kannan S; Teuben R; DiSilvestre D; Morrissette-McAlmon J; Saffitz JE; Boheler KR; James CA; Chelko SP; Tomaselli G; Tung L
    J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
    Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
    Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hyperpolarization-Activated Cyclic-Nucleotide-Gated Channel Blocker Ivabradine Does Not Prevent Arrhythmias in Catecholaminergic Polymorphic Ventricular Tachycardia.
    Bueno-Levy H; Weisbrod D; Yadin D; Haron-Khun S; Peretz A; Hochhauser E; Arad M; Attali B
    Front Pharmacol; 2019; 10():1566. PubMed ID: 32009964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3β.
    Padrón-Barthe L; Villalba-Orero M; Gómez-Salinero JM; Domínguez F; Román M; Larrasa-Alonso J; Ortiz-Sánchez P; Martínez F; López-Olañeta M; Bonzón-Kulichenko E; Vázquez J; Martí-Gómez C; Santiago DJ; Prados B; Giovinazzo G; Gómez-Gaviro MV; Priori S; Garcia-Pavia P; Lara-Pezzi E
    Circulation; 2019 Oct; 140(14):1188-1204. PubMed ID: 31567019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.
    Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D
    Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of arrhythmogenic right ventricular cardiomyopathy presenting with progressive right ventricular failure and recurrent multifocal monomorphic ventricular tachycardia during 15 years of follow-up.
    Kuwabara K; Hirata K; Wake M; Takahashi T; Nakazato J; Yagi N; Fukuyama A
    J Cardiol Cases; 2014 Dec; 10(6):216-220. PubMed ID: 30534247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.
    Bosman LP; Sammani A; James CA; Cadrin-Tourigny J; Calkins H; van Tintelen JP; Hauer RNW; Asselbergs FW; Te Riele ASJM
    Heart Rhythm; 2018 Jul; 15(7):1097-1107. PubMed ID: 29408436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
    Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
    Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Calkins H; Corrado D; Marcus F
    Circulation; 2017 Nov; 136(21):2068-2082. PubMed ID: 29158215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
    Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connexin expression patterns in arrhythmogenic right ventricular cardiomyopathy.
    Paul M; Wichter T; Gerss J; Arps V; Schulze-Bahr E; Robenek H; Breithardt G; Weissen-Plenz G
    Am J Cardiol; 2013 May; 111(10):1488-95. PubMed ID: 23465095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling Reentry in the Short QT Syndrome With Human-Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets.
    Shinnawi R; Shaheen N; Huber I; Shiti A; Arbel G; Gepstein A; Ballan N; Setter N; Tijsen AJ; Borggrefe M; Gepstein L
    J Am Coll Cardiol; 2019 May; 73(18):2310-2324. PubMed ID: 31072576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmic outcome of arrhythmogenic right ventricular cardiomyopathy patients without implantable defibrillators.
    Wang W; Cadrin-Tourigny J; Bhonsale A; Tichnell C; Murray B; Monfredi O; Chrispin J; Crosson J; Tandri H; James CA; Calkins H
    J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1396-1402. PubMed ID: 29894017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysosomal Ca
    Xie A; Kang GJ; Kim EJ; Feng F; Givens SE; Ogle BM; Dudley SC
    PNAS Nexus; 2023 Jun; 2(6):pgad174. PubMed ID: 37303713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.